跳至主要内容
临床试验/NCT03538431
NCT03538431已完成4 期

Improving Driving in Young People With Autism Spectrum Disorders

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2018年10月31日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
26
试验地点
1
主要终点
Heart Rate

研究概览

简要总结

This study will examine the effects of treatment with the anti-anxiety medicine buspirone on driving performance (eye tracking) in individuals with high-functioning autism spectrum disorder (HF-ASD).

The study consists of an Assessment Visit at Massachusetts General Hospital (MGH), as well as two Driving Simulation visits that will take place at Massachusetts Institute of Technology (MIT). Subjects will be given buspirone and asked to take the medication for the two days preceding the Driving Simulation Visit.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 24 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females, ages 18-24, with a diagnosis of DSM-V Autism Spectrum Disorder
  • Has a valid Driver's License

排除标准

  • Major sensorimotor handicaps (e.g. deafness, blindness)
  • Individuals who have never held a valid driver's license
  • Intellectual Deficiency (Verbal Comprehension Index < 80)
  • Inadequate command of the English language
  • Subjects with any clinically meaningful medical or psychiatric condition as determined by the investigator
  • Individuals who are currently taking a monoamine oxidase inhibitor (MAOI) for any reason

研究组 & 干预措施

Buspirone

Experimental

These subjects will receive buspirone prior to engaging in the driving simulation.

干预措施: Buspirone (Drug)

Unmedicated

Experimental

These subjects will take no medication prior to engaging in the driving simulation

干预措施: Buspirone (Drug)

结局指标

主要结局

Heart Rate

时间窗: Up to 6 weeks

Hyperarousal will be measured by heart rate during participants' time in the driving simulation.

Driving Performance - Measured by Mean Off-Road Glance Duration

时间窗: Up to 6 weeks

Driving performance will be analyzed using eye tracking in individuals with Autism Spectrum Disorder while on the anti-anxiety medication buspirone and while not on buspirone. Eye movement behavior (measured by glance duration) during the driving simulation was manually coded on a frame-by-frame basis from recorded video by trained coders for all cases where usable video recordings were available for both the medicated and non-medicated driving simulation sessions per participant.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Joseph Biederman, MD

Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验